CRVS Earnings

Quarterly EPS
$-0.60
Q3 2024
$-0.18
Q4 2024
$0.21
Q1 2025
$-0.10
Q2 2025
$-0.12
Q3 2025
$-0.15
Q4 2025
$-0.15
Q1 2026
$-0.19
Q2 2026
Latest RevenueN/A
Latest Net Income-17959000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.190-17959000-90.0%
Q1 2026-$0.150-13692000-171.4%
Q4 2025-$0.150-12321000+16.7%
Q3 2025-$0.120-10157000+80.0%
Q2 2025-$0.100-7998000-42.9%
Q1 2025$0.21015.2M+275.0%
Q4 2024-$0.180-12113000-28.6%
Q3 2024-$0.600-40217000-400.0%
Q2 2024-$0.070-4262000
Q1 2024-$0.120-5701000
Q4 2023-$0.140-6653000
Q3 2023-$0.120-6000000
Corvus Pharmaceuticals (CRVS) — Earnings